179 related articles for article (PubMed ID: 29422387)
1. Discovery of novel potent HCV NS5B polymerase non-nucleoside inhibitors bearing a fused benzofuran scaffold.
Zhong M; Peng E; Huang N; Huang Q; Huq A; Lau M; Colonno R; Li L
Bioorg Med Chem Lett; 2018 Mar; 28(5):963-968. PubMed ID: 29422387
[TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of novel tetracyclic benzofurans as palm site allosteric inhibitors of HCV NS5B polymerase.
Liu H; Dai X; He S; Brockunier L; Marcantonio K; Ludmerer SW; Li F; Feng KI; Nargund RP; Palani A
Bioorg Med Chem Lett; 2019 Dec; 29(24):126104. PubMed ID: 30389294
[TBL] [Abstract][Full Text] [Related]
3. Multi-step parallel synthesis enabled optimization of benzofuran derivatives as pan-genotypic non-nucleoside inhibitors of HCV NS5B.
Xiao D; Dai X; Liu H; He S; Shi ZC; Ludmerer SW; Li F; Nargund R; Palani A
Bioorg Med Chem Lett; 2020 Apr; 30(7):127004. PubMed ID: 32061500
[TBL] [Abstract][Full Text] [Related]
4. New pseudodimeric aurones as palm pocket inhibitors of Hepatitis C virus RNA-dependent RNA polymerase.
Meguellati A; Ahmed-Belkacem A; Nurisso A; Yi W; Brillet R; Berqouch N; Chavoutier L; Fortuné A; Pawlotsky JM; Boumendjel A; Peuchmaur M
Eur J Med Chem; 2016 Jun; 115():217-29. PubMed ID: 27017550
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of 3,4-dihydro-1H-[1]-benzothieno[2,3-c]pyran and 3,4-dihydro-1H-pyrano[3,4-b]benzofuran derivatives as non-nucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase.
Gopalsamy A; Aplasca A; Ciszewski G; Park K; Ellingboe JW; Orlowski M; Feld B; Howe AY
Bioorg Med Chem Lett; 2006 Jan; 16(2):457-60. PubMed ID: 16274990
[TBL] [Abstract][Full Text] [Related]
6. 2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymerase.
Küçükgüzel I; Satılmış G; Gurukumar KR; Basu A; Tatar E; Nichols DB; Talele TT; Kaushik-Basu N
Eur J Med Chem; 2013 Nov; 69():931-41. PubMed ID: 24161679
[TBL] [Abstract][Full Text] [Related]
7. Recent advances on the synthesis of hepatitis C virus NS5B RNA-dependent RNA-polymerase inhibitors.
Zhao C; Wang Y; Ma S
Eur J Med Chem; 2015 Sep; 102():188-214. PubMed ID: 26276434
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a novel series of non-nucleoside thumb pocket 2 HCV NS5B polymerase inhibitors.
Stammers TA; Coulombe R; Rancourt J; Thavonekham B; Fazal G; Goulet S; Jakalian A; Wernic D; Tsantrizos Y; Poupart MA; Bös M; McKercher G; Thauvette L; Kukolj G; Beaulieu PL
Bioorg Med Chem Lett; 2013 May; 23(9):2585-9. PubMed ID: 23545108
[TBL] [Abstract][Full Text] [Related]
9. Novel 4-thiazolidinones as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase.
Çakir G; Küçükgüzel İ; Guhamazumder R; Tatar E; Manvar D; Basu A; Patel BA; Zia J; Talele TT; Kaushik-Basu N
Arch Pharm (Weinheim); 2015 Jan; 348(1):10-22. PubMed ID: 25449674
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiviral properties of novel 7-heterocyclic substituted 7-deaza-adenine nucleoside inhibitors of Hepatitis C NS5B polymerase.
Di Francesco ME; Avolio S; Pompei M; Pesci S; Monteagudo E; Pucci V; Giuliano C; Fiore F; Rowley M; Summa V
Bioorg Med Chem; 2012 Aug; 20(15):4801-11. PubMed ID: 22770556
[TBL] [Abstract][Full Text] [Related]
11. The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase.
LaPorte MG; Draper TL; Miller LE; Blackledge CW; Leister LK; Amparo E; Hussey AR; Young DC; Chunduru SK; Benetatos CA; Rhodes G; Gopalsamy A; Herbertz T; Burns CJ; Condon SM
Bioorg Med Chem Lett; 2010 May; 20(9):2968-73. PubMed ID: 20347591
[TBL] [Abstract][Full Text] [Related]
12. Quinolones as HCV NS5B polymerase inhibitors.
Kumar DV; Rai R; Brameld KA; Somoza JR; Rajagopalan R; Janc JW; Xia YM; Ton TL; Shaghafi MB; Hu H; Lehoux I; To N; Young WB; Green MJ
Bioorg Med Chem Lett; 2011 Jan; 21(1):82-7. PubMed ID: 21145235
[TBL] [Abstract][Full Text] [Related]
13. Non-nucleoside inhibitors of HCV NS5B polymerase. Part 1: Synthetic and computational exploration of the binding modes of benzothiadiazine and 1,4-benzothiazine HCV NS5b polymerase inhibitors.
Hendricks RT; Fell JB; Blake JF; Fischer JP; Robinson JE; Spencer SR; Stengel PJ; Bernacki AL; Leveque VJ; Le Pogam S; Rajyaguru S; Najera I; Josey JA; Harris JR; Swallow S
Bioorg Med Chem Lett; 2009 Jul; 19(13):3637-41. PubMed ID: 19447623
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase.
Pierra Rouvière C; Amador A; Badaroux E; Convard T; Da Costa D; Dukhan D; Griffe L; Griffon JF; LaColla M; Leroy F; Liuzzi M; Loi AG; McCarville J; Mascia V; Milhau J; Onidi L; Paparin JL; Rahali R; Sais E; Seifer M; Surleraux D; Standring D; Dousson C
Bioorg Med Chem Lett; 2016 Sep; 26(18):4536-4541. PubMed ID: 27520942
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.
Yeung KS; Beno BR; Parcella K; Bender JA; Grant-Young KA; Nickel A; Gunaga P; Anjanappa P; Bora RO; Selvakumar K; Rigat K; Wang YK; Liu M; Lemm J; Mosure K; Sheriff S; Wan C; Witmer M; Kish K; Hanumegowda U; Zhuo X; Shu YZ; Parker D; Haskell R; Ng A; Gao Q; Colston E; Raybon J; Grasela DM; Santone K; Gao M; Meanwell NA; Sinz M; Soars MG; Knipe JO; Roberts SB; Kadow JF
J Med Chem; 2017 May; 60(10):4369-4385. PubMed ID: 28430437
[TBL] [Abstract][Full Text] [Related]
16. Structure-based optimization and derivatization of 2-substituted quinolone-based non-nucleoside HCV NS5B inhibitors with submicromolar cellular replicon potency.
Cheng Y; Shen J; Peng RZ; Wang GF; Zuo JP; Long YQ
Bioorg Med Chem Lett; 2016 Jun; 26(12):2900-2906. PubMed ID: 27133482
[TBL] [Abstract][Full Text] [Related]
17. Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors.
Mish MR; Cho A; Kirschberg T; Xu J; Zonte CS; Fenaux M; Park Y; Babusis D; Feng JY; Ray AS; Kim CU
Bioorg Med Chem Lett; 2014 Jul; 24(14):3092-5. PubMed ID: 24907145
[TBL] [Abstract][Full Text] [Related]
18. Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase.
Talele TT; Arora P; Kulkarni SS; Patel MR; Singh S; Chudayeu M; Kaushik-Basu N
Bioorg Med Chem; 2010 Jul; 18(13):4630-8. PubMed ID: 20627595
[TBL] [Abstract][Full Text] [Related]
19. Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: structure-based design and synthesis of new templates.
Malancona S; Donghi M; Ferrara M; Martin Hernando JI; Pompei M; Pesci S; Ontoria JM; Koch U; Rowley M; Summa V
Bioorg Med Chem; 2010 Apr; 18(8):2836-48. PubMed ID: 20363140
[TBL] [Abstract][Full Text] [Related]
20. The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2'-α-chloro-2'-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitors.
Alexandre FR; Badaroux E; Bilello JP; Bot S; Bouisset T; Brandt G; Cappelle S; Chapron C; Chaves D; Convard T; Counor C; Da Costa D; Dukhan D; Gay M; Gosselin G; Griffon JF; Gupta K; Hernandez-Santiago B; La Colla M; Lioure MP; Milhau J; Paparin JL; Peyronnet J; Parsy C; Pierra Rouvière C; Rahali H; Rahali R; Salanson A; Seifer M; Serra I; Standring D; Surleraux D; Dousson CB
Bioorg Med Chem Lett; 2017 Sep; 27(18):4323-4330. PubMed ID: 28835346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
